Clinical Trial

Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions

Study acronym: DELiso
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to examine if older patients who need to be under isolation precautions due to multidrug resistant bacteria or other reasons have an increased risk of suffering from delirium or cognitive decline compared to older patients without isolation precautions. To compare this, every person under isolation precautions is compared to other persons of the same age, gender, comorbidities, frailty status and hospital department. Delirium is assessed twice daily with a screening tool named 3D-CAM and cognitive performance is tested by the MOCA-Test six weeks after discharge from hospital and compared to baseline values which are assessed directly after study enrollment. The study duration for each patient participating is from the time of enrollment during hospitalization until 6 weeks after hospital discharge.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-24
Trial Details
NCT Number NCT07114458
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Conditions Delirium, Dementia, Cognitive Impairment
Enrollment 404 participants
Start Date 2025-08-05
Primary Completion 2027-04 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-23